LWAC
TNDM icon

Laurel Wealth Advisors (California)’s Tandem Diabetes Care TNDM Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,432
Closed -$282K – 752
2022
Q1 		$282K Sell
2,432
-220
-8% -$25.7K 0.02% 605
2021
Q4 		$400K Buy
+2,652
New +$358K 0.03% 535
2021
Q3 		– Sell
-2,632
Closed -$256K – 506
2021
Q2 		$256K Buy
+2,632
New +$235K 0.03% 437

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Laurel Wealth Advisors (California)'s TNDM Position: Q2 2022 in Review

Laurel Wealth Advisors (California) sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,432 shares — an estimated $282K sold.

Laurel Wealth Advisors (California) first reported a position in TNDM in Q2 2021 and held it in 3 quarters. The position peaked at $400K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Laurel Wealth Advisors (California) reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 2,432 Tandem Diabetes Care shares in Q2 2022, an estimated $282K.
  • Laurel Wealth Advisors (California) first reported a position in Tandem Diabetes Care in Q2 2021 and held it in 3 quarters.
  • Laurel Wealth Advisors (California)'s Tandem Diabetes Care position peaked at $400K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q2 2022, filed 12 Aug 2022.